So far so good, yes. However, the company said nothing about meeting the requirements of the schedule going forward. Instead they said this in the heading: "Telzuit continues to fine tune product and is not yet ready for expanded roll-out of the STATPATCH System. " And, in the release: "He further noted that Telzuit has additional work to complete on the STATPATCH System, but that the current release of the product provides the same information to the physician as a traditional Holter monitor".
"Not yet ready for expanded roll-out" and "has additional work" are not reassuring to investors who want to know if they intend to stay on schedule going forward. Maybe a call to the company is advisable here. Good luck,
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.